Scynexis (SCYX) Accounts Payables (2013 - 2026)
Scynexis' (SCYX) quarterly Accounts Payables came in at $5.6 million in Q1 2026, up 32.21% YoY from $4.3 million in Q1 2025, and up 153.12% on a QoQ basis from $2.2 million in Q4 2025.
Scynexis (SCYX) Accounts Payables (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Accounts Payables data on file, last reported at $5.6 million in Q1 2026.
- Quarterly Accounts Payables rose 32.21% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 32.21% YoY) and the FY2025 annual result came in at $2.2 million, down 51.3% from the prior year.
- Accounts Payables climbed to $5.6 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $10.0 million in Q2 2022 to a low of $2.2 million in Q4 2025.
- A 5-year average of $5.7 million and a median of $5.6 million in 2026 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 67.51% — and 2023, when it slumped 65.7%.
- Tracing SCYX's Accounts Payables over 5 years: stood at $5.9 million in 2022, then increased by 20.41% to $7.1 million in 2023, then slumped by 36.09% to $4.6 million in 2024, then slumped by 51.3% to $2.2 million in 2025, then jumped by 153.12% to $5.6 million in 2026.
- The last three Accounts Payables figures came in at $5.6 million (Q1 2026), $2.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | 3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 5.63 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 7.15 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 7.85 Mn |
| Sep 30, 2021 | 7.51 Mn |